Translating ECHOS2 Into an mHealth Platform

Sponsor
Washington University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05923242
Collaborator
St. Jude Children's Research Hospital (Other)
50
1
1
5.3
9.5

Study Details

Study Description

Brief Summary

Childhood cancer survivors are at an increased risk of cardiac toxicity due to prior anti-cancer therapy. However, adherence to cardiac screening in this population remains low. This study aims to assess the feasibility of an mHealth motivational interviewing platform called Computerized Authoring Intervention Software (CIAS) in childhood cancer survivors. Participants will be recruited from the Childhood Cancer Survivorship Study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Computerized Intervention Authoring Software (CIAS)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of Cardiovascular Health Outcomes Among Survivors 2 (ECHOS2) Pilot Intervention: Translating ECHOS Into an mHealth Platform
Anticipated Study Start Date :
Jul 31, 2023
Anticipated Primary Completion Date :
Jan 7, 2024
Anticipated Study Completion Date :
Jan 7, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Computerized Intervention Authoring Software (CIAS)

Participants will be provided with a link to begin the study following consent, and the link will direct the participants to a baseline survey. At the end of the survey, participants will be automatically redirected to Computerized Intervention Authoring Software (CIAS). Participants will be encouraged to complete 2 sessions in CIAS, approximately 1 week apart. After completing the second session, CIAS will automatically redirect the participants to a post-test survey. Approximately 30 days after completing the second session, participants will be invited to complete a 30 day follow-up survey.

Behavioral: Computerized Intervention Authoring Software (CIAS)
CIAS is a web based intervention. The CIAS tool walks the participant through a Motivational Interviewing process whereby they think through the reasons for and against completing screening. CIAS makes use of an automated avatar (Emmi) who is programed to ask them questions and lead them through several topic areas related to screening. The CIAS pathways include options for participants to request a link of resources after they complete each session and for patients to request a list of the cancer treatments listed in their study records in order to confirm their understanding of their cancer history.

Outcome Measures

Primary Outcome Measures

  1. Change in health belief model (HBM) construct scale of knowledge about echocardiograms and the effects of their treatment on health [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their knowledge of echocardiograms and the effects of their treatment on health on a 3 point scale consisting of possible answers of yes, no, and "don't know", with "don't know" being scored as incorrect. The scoring will be the summary of correct responses.

  2. Change in self-determination theory (SDT) construct scale of competence, defined by confidence in getting an echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their confidence in getting an echocardiogram on a Likert scale with multiple choice between 0 to 10 with 0 indicating not at all sure and 10 indicating extremely sure. Scores will range from 0 and 10 with a higher value indicating higher confidence.

  3. Change in self-determination theory (SDT) construct scale of autonomy, defined by the perceived choice of getting an echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their perceived choice of getting an echocardiogram on a 5-point Likert scale with 1 indicating disagree strongly and 5 indicating agree strongly. Scores will range from 3 to 15 with a higher score indicating higher perceived choice.

  4. Change in self-determination theory (SDT) construct scale of relatedness, as defined by the effect of social norms/influence on the patient's decision of getting echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about the effects of social norms/influence on a 5-point Likert scale with 1 indicating disagree strongly and 5 indicating agree strongly. Scores will range from 6 to 30 with a higher score indicating more effect of social norms and influence on the patient's decision.

  5. Change in movement toward screening [From post-test survey to 1 month follow-up (expected to be about 1 month and 1 week)]

    Movement toward screening will consist of checking if patient made a plan to set an appointment with healthcare provider to discuss screening, made an appointment to discuss screening, had appointment to discuss screening, scheduled screening, or obtained screening, and if this plan changed between post-test survey and 1 month follow-up.

Secondary Outcome Measures

  1. Change in health belief model (HBM) construct scale of perceived risk of having heart problems [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their perceived risk of having heart problems on a 5 point scale, with 1 indicating no likelihood of heart problems, and 5 indicating extremely likely. Scores will range from 1 to 5 with a higher score indicating more perceived risk.

  2. Change in health belief model (HBM) construct scale of perceived severity of having heart problems [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their perceived severity of heart problems on a 5 point scale, with 1 indicating not serious and 5 indicating extremely serious. Scores will range from 1 to 5 with a higher score indicating higher perceived severity.

  3. Change in health belief model (HBM) construct scale of perceived barriers to getting echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their perceived barriers to getting an echocardiogram on a 5-point Likert scale with 1 indicating disagree strongly and 5 indicating agree strongly. Scores will range from 6 to 30 with a higher score indicating fewer perceived barriers.

  4. Change in health belief model (HBM) construct scale of perceived benefits of getting echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their perceived benefits of getting an echocardiogram on a 5-point Likert scale with 1 indicating disagree strongly and 5 indicating agree strongly. Scores will range from 6 to 30 with a higher score indicating more perceived benefits.

  5. Change in health belief model (HBM) construct scale of overall self-efficacy of getting echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their overall self-efficacy of getting an echocardiogram on a 5-point Likert scale with 1 indicating disagree strongly and 5 indicating agree strongly. Scores will range from 3 to 15 with a higher score indicating higher overall self-efficacy.

  6. Change in health belief model (HBM) construct scale of worry about having heart problems [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their worry about having heart problems on a 5-point scale with 1 indicating not worried at all and 5 indicating extremely worried. Scores will range from 1 to 5 with a higher score indicating more worry.

  7. Change in health belief model (HBM) construct scale intentions of getting echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their intentions of getting an echocardiogram on a 5-point Likert scale with 1 indicating disagree strongly and 5 indicating agree strongly. Scores will range from 3 to 15 with a higher score indicating a higher intention of getting an echocardiogram.

  8. Change in self-determination theory (SDT) construct scale of intrinsic motivation, defined by the perceived importance of getting an echocardiogram [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their perceived importance of getting an echocardiogram on both a Likert scale with multiple choice between 0 to 10 with 0 indicating not at all important and 10 indicating extremely important, and a 5-point Likert scale with 1 indicating disagree strongly and 5 indicating agree strongly. Scores will range from 8 to 50 with a higher value indicating higher perceived importance.

  9. Change in self-determination theory (SDT) construct scale of intrinsic motivation, defined by decision-making readiness [From baseline survey to post-test survey (expected to be about 1 week)]

    Patients will be asked about their decision-making readiness in getting an echocardiogram on a Likert scale with multiple choice between 0 to 10 with 0 indicating not at all ready and 10 indicating extremely ready. Scores will range from 0 to 10 with a higher score indicating higher decision-making readiness.

  10. Implementation process outcome of engagement with the app as measured by the time spent on the app [Through the second CIAS session (expected to be about 1 week)]

    This will be defined as the total time spent on the app during session 1 and session 2.

  11. Implementation process outcome of engagement with the app as measured by the number of modules started/completed [Through the second CIAS session (expected to be about 1 week)]

    This will be defined as the total number of modules started and total number of modules completed on the app during session 1 and session 2.

  12. Implementation process outcome of engagement with the app as measured by the number of sessions started/completed [Through the second CIAS session (expected to be about 1 week)]

    This will be defined as the total number of sessions started and total number of sessions completed on the app during session 1 and session 2.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years of age or older

  • Diagnosed with cancer at age 17 or younger

  • 2 or more years after completion of cancer therapy

  • Receipt of cardiotoxic therapy (Any dose of anthracycline or 15 Gy chest radiation involving cardiac structures)

  • No history of cardiomyopathy

  • Have not received an echocardiogram in the past 5 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University School of Medicine Saint Louis Missouri United States 63110

Sponsors and Collaborators

  • Washington University School of Medicine
  • St. Jude Children's Research Hospital

Investigators

  • Principal Investigator: Erika Waters, PhD, MPH, Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT05923242
Other Study ID Numbers:
  • 202305110
First Posted:
Jun 28, 2023
Last Update Posted:
Jun 28, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Washington University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2023